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During the past decades, a large body of information concerning the eﬀects of endocrine disrupting compounds (EDCs) on
animals and humans has been accumulated. EDCs are of synthetic or natural origin and certain groups are known to disrupt
the action of androgens and to impair the development of the male reproductive tract and external genitalia. The present
overviewdescribestheeﬀectsofthediﬀerentclassesofEDCs,suchaspesticides,phthalates,dioxins,andphytoestrogens,including
newly synthesized resveratrol analogs on steroidogenesis in Leydig cells. The potential impact of these compounds on androgen
production by Leydig cells during fetal development and in the adult age is discussed. In addition, the possible role of EDCs in
connection with the increasing frequency of abnormalities in reproductive development in animals and humans is discussed.
1.Introduction
Androgens play a critical role in the development of the
normal male phenotype. Disruption of androgen biosyn-
thesis and actions by environmental endocrine disrupting
compounds (EDCs), of synthetic or natural origin chemicals
(Table 1), inhibiting critical cellular processes controlling
steroidogenesis in Leydig cells (e.g., transport and delivery
of cholesterol into mitochondria, steroidogenic enzyme
expression or activity) and androgen binding to the andro-
gens receptor (AR) may lead to incomplete masculinization
and malformations in the male reproductive tract of both
humans and animals. Androgen deﬁciency during prenatal
development is thought to disturb diﬀerentiation of the
Wolﬃan duct,a processcrucialto the proper development of
male internal reproductive organs. An increase in a number
of human male reproductive developmental disorders such
as cryptorchidism, hypospadias, testicular cancer, as well as
decreased quality of semen all have all been proposed to
be due to the action of EDCs. It has been hypothesized
that EDCs play a role in the etiology of these abnormalities,
collectively termed testicular dysgenesis syndrome (TDS)
[1]. Reliable data on the prevalence of TDS are scarse but
>5% of the Danish male population was reported to suﬀer
from undescended testes, hypospadia, or testicular cancer
[2]. Moreover, the recent ﬁnding of an age-independent
decrease in testosterone and sex hormone-binding globulin
(SHBG)levelsinUSandDanishpopulationsoverthepast20
years indicate an environmental inﬂuence such as a growing
negative eﬀect of EDCs on androgen production by Leydig
cells. In addition, recent ﬁndings have demonstrated the
associationbetweenexposurestoEDCsandthedevelopment
of obesity [3], a factor that may cause increased estrogenic
eﬀects on the humans and attenuate Leydig cell function and
fertility [4].
The aim of this paper is to give an overview of the
published literature on the eﬀects of EDCs on Leydig cell
function and steroidogenesis with particular focus on male
reproduction and fertility.
2.Leydig CellPopulations
Two distinct generations of Leydig cells have been identiﬁed:
fetal Leydig cells (FLCs) and adult Leydig cells. Despite their
diﬀerences in morphological and biochemical properties,
fetal and adult Leydig cells share the same principal function
to produce androgens.
2.1. Fetal Leydig Cells. During the prenatal period, the
(FLCs) are the primary source of androgens. These cells then
secrete testosterone and other androgens, which regulate2 Journal of Biomedicine and Biotechnology
Table 1: Natural and synthetic chemicals aﬀecting Leydig cell function.
Chemical Proposed target Application or source
Procymidone Androgen receptor antagonist Fungicide, control of plant diseases
Linuron Androgen receptor antagonist Herbicide, postemergence control
of weeds in crops
Vinclozolin Androgen receptor antagonist Fungicide
p,p DDT Androgen receptor antagonist Pesticide
Dioxins Aryl hydrocarbon receptor agonist By-product of chlorinated
hydrocarbons
Phthalates Peroxisome proliferator-activated
receptors (PPARs)? Plasticizers
Genistein ERs stimulator Soy-derived food
Resveratrol ERs stimulator Red wine, red grape
Bisphenol A ERs stimulator Synthesis of polycarbonate plastics
Corresponding references are present in the text.
not only the masculinization of internal and external male
genitalia, but also neuroendocrine functions. FLCs start to
appear in the mesenchyme of the developing prenatal testis
at E12.5 in mice, E14.5 in rats, and 7-8 weeks of gestation
in human. FLCs undergo diﬀerentiation from precursor
cells and their numbers increase signiﬁcantly. In rats, FLC
numbers increase from 2.5 × 104 per testis at E17 to about
1×105 cellspertestisatE21[5].Theythenmarkedlydecrease
during several weeks after birth [6].
In the male fetus, FLCs seem to arise from multi-
ple sources including the coelomic epithelium, gonadal
ridge mesenchyme, and migrating mesonephric cells [7, 8].
Endothelialcellsmigratingfromthemesonephroscontribute
to precursors of the peritubular myoid and vascular cell
lineages [9, 10] and may also serve as the origin of fetal
Leydig cells. There is also opinion that FLCs due to their
expression of neuronal proteins may have origin from
neural crest cells [11]. Moreover, it has been suggested that
the FLCs may have ﬁrst evolved from slight modiﬁcations
o ff e t a la d r e n a lc e l l s[ 8]. This hypothesis is supported
by the ﬁnding that adrenal cortex and gonads are both
derived from the common adrenal-gonadal primordium
before they separate into separate organs [8]. FLCs possess
a well-developed steroidogenic machinery expressing the key
steroidogenic enzymes, such as steroidogenic acute regula-
tory(StAR)protein,cytochromeP450scc,3β-hydroxysteroid
dehydrogenase-isomerase (3βHSD), cytochrome P450c17,
and 5α-reductase (5α-R) required for androgen synthe-
sis. Testosterone secreted by FLCs is required for mas-
culinization and proper development of male reproductive
organs. This steroid produced by FLCs is converted to 5α-
dihydrotestosterone (DHT) by the enzyme 5α-R. DHT is a
more potent androgen than testosterone and controls proper
development of male external genitalia (e.g., the penis and
scrotum) and the release of the testis from its urogenital
ridgelocation[12].Experiments onanimalshaveshownthat
disruption of FLCs development results in feminization of
external genitalia due to lack of androgens required for their
masculinization [13]. Moreover, FLCs also produce insulin-
like factor 3 (Insl3), a protein that plays a critical role in the
regulation of the early phase of testicular descent [14]. Thus,
FLC dysfunction may lead to incomplete masculinization
and various malformations in the male reproductive tract of
humans and animals (e.g., cryptorchidism and hypospadia).
2.2. Adult Leydig Cell Population. A d u l tL e y d i gc e l l so r i g i -
nate postnatally and produce testosterone required for the
pubertal development of external genitalia and onset of sper-
matogenesis, the important endocrine functions apparent
at the onset of puberty. Adult Leydig cells are not derived
from preexisting fetal Leydig cells, but most likely from
undiﬀerentiated peritubular-like stem cells, which express
bothstemandperitubularcellmarkers[15].TheLeydigstem
cells proliferate neonatally and transform to progenitor cells
by day 14 postpartum in rodents. Leydig cell progenitors
are intermediates in the Leydig cell lineage. They have
spindle shape and classify as Leydig cells because they
express luteinizing hormone (LH) receptor and low levels
of steroidogenic enzymes (e.g., 3β-hydroxysteroid dehydro-
genase (3β-HSD), cytochrome P45017α-hydroxylase/C17-20
lyase (P450c17), 17β-hydroxysteroid dehydrogenase (17β-
HSD)) and produce low but detectable levels of androgens
[16, 17]. This type of Leydig cell exists for only a brief
interval, postnatal days 14–28 in rats. During that time
the cells proliferate, diﬀerentiate and give rise to immature
Leydig cells. Immature Leydig cells function during day 28 to
56 and express high levels of steroidogenic enzymes involved
in the biosynthesis and metabolism of testosterone (e.g.,
5α-reductase and 3α-HSD), and therefore secrete more 5α-
reduced androgens than testosterone [18]. A distinguishing
characteristic of immature Leydig cells is their numerous
cytoplasmic lipid droplets [19]. Immature Leydig cells divide
once before diﬀerentiating into adult Leydig cells. Adult
Leydig cells have low numbers of lipid drops, higher number
of LH receptors, and the major androgen produced by the
cells is testosterone due to enhanced expression of 17-KSR
and suppression in the activities of 5α-reductase and 3α-
HSD.Journal of Biomedicine and Biotechnology 3
3. Steroidogenesis
Steroidogenesis in Leydig cells is regulated mainly by
LH, a glycoprotein produced by the anterior pituitary.
Binding of LH to its 7-transmembrane G-protein coupled
receptor stimulates adenylate cyclase activity, resulting in
increased cyclic adenosine monophosphate (cAMP) forma-
tion [20]. cAMP stimulates the cAMP-dependent protein
kinase (PKA), which phosphorylates serine and threonine
residues on speciﬁc protein substrates [21]. cAMP activates
steroidogenesis by temporally distinct manners; acutely
(minutes) or chronically (hours). The delivery of choles-
terol molecules into the inner mitochondrial membrane
is generally accepted to be the rate-determining step in
steroidogenesis [22]. The cholesterol transport mechanism
is a complex process, involving an interaction between
the steroidogenic acute regulatory (StAR) protein and the
peripheral-type benzodiazepine receptor (PBR) [23, 24].
StAR expression is upregulated by trophic hormones, and
after synthesis as a 37-kDa precursor protein, it needs to be
processedtoa30-kDamatureproteintobecomefunctionally
active [23]. PBR has high aﬃnity to bind cholesterol from
cytosolic donors and transfers it from the outer into the
inner mitochondrial membrane [24]. StAR and PBR are
suggestedtoworkcoordinatelyintheprocessoftransporting
cholesterol into mitochondria, where StAR is functioning as
an initiator of cholesterol transport and PBR as a gate for
cholesterol entry into mitochondria [25]. Once cholesterol
reachestheinnermitochondrialmembrane,itisimmediately
converted into pregnenolone. This reaction is one of the
rate-limiting in steroidogenesis [14] and catalysed by the
cytochrome P450 enzyme CYP11A1 and speciﬁc electron
transferring proteins, localized at the inner mitochondrial
membrane [14]. Pregnenolone then leaves the mitochondria
to the smooth endoplasmic reticulum, where it is converted
by 3β-HSD to progesterone. This steroid is then metabolised
by P450c17 to androstenedione, which is converted to
testosterone by 17β-HSD [14].
4. Effects of EnvironmentalAntiandrogenson
Hormonal Function of Leydig Cells
Environmental anthropogenic compounds may exert anti-
androgenic eﬀects. The pesticides procymidone, linuron,
vinclozolin, p,p -DDT and its derivatives, are all antagonists
of AR and inhibit androgen-dependent tissue growth in vivo
[26]. None of these pesticides or their metabolites appears
to display signiﬁcant aﬃnity for the estrogen receptor or to
inhibit 5α-reductase activity in vitro [27].
4.1. Procymidone. Procymidone (N-(3,5-dichlorophenyl)-
1,2-dimethyl-cyclopropane-1,2-dicarboximide) is widely
used as a fungicide for the control of plant diseases.
This compound possesses weak anti-androgenic activity
and may induce hypergonadotropism [28]. High mg
quantities of procymidone were found in unhusked rice
(1.4–2.3mg/kg), tomatoes (about 5mg/kg), grapes, and
wine (US Environmental Protection Agency annual report,
1994) suggesting that an intake of signiﬁcant quantities of
this compound in the human is possible.
Long-term administration of procymidone is suggested
to inhibit the negative feedback exerted by androgens on
the hypothalamus and/or the pituitary, thereby causing
hypergonadotropisminrats.Thelesserabilityoftestosterone
to bind AR in this situation suppresses the inhibitory
feedback of testosterone on LH production by preventing the
hypothalamus and anterior pituitary from recognizing the
presence of testosterone. This results in hypersecretion of LH
with concomitant elevation of serum testosterone (Figure 1).
Long-term hypergonadotropism and hyperstimulation of
Leydig cells induced by procymidone give rise to Leydig cell
tumors in male rats [29]. Recent ﬁndings from our own lab-
oratory reveal that dietary administration of procymidone to
rats for three months not only enhances serum levels of LH
and testosterone, but that the Leydig cells isolated from these
animals display an enhanced capacity for producing testos-
terone in response to stimulation by hCG or (Bu)2cAMP, as
well as elevated levels of StAR, P450scc, and P450c17 [30].
4.2. Linuron. Linuron (3-(3,4-dichlorophenyl)-1-methoxy-
1-methylurea)ismarketedasaselectiveurea-basedherbicide
for pre- and/or postemergence control of weeds in crops and
potatoes. This compound binds to both rat prostatic and
human AR (hAR) and inhibits DHT-induced gene expres-
sion in vitro [31]. The anti-androgenic eﬀect of linuron
is observed clearly upon administration during gestation
[32, 33] or in a Hershberger assay [33]. Administration of
linuron (200mg/kg daily) to sexually immature and mature
rats for 2 weeks results in decreased weights of accessory sex
organs and increased serum estradiol and LH levels, without
altering the serum concentration of testosterone [31]. In
contrast,prenatalexposuretolinuron(75mg/kg/day)during
gestational days 14–18 in rats has recently been shown to
decrease testosterone production by fetal Leydig cells [34].
This latter study suggests that linuron disrupts the develop-
ment of androgen-dependent tissues primarily by acting as
an AR antagonist and by inhibiting testosterone synthesis by
the fetal testis. This suggestion agrees well with the evidence
that in utero exposure to potent pharmaceutical antagonist
of AR, ﬂutamide decreases the expression levels of SF-1,
Insl3,and3βHSDinthedevelopingfetalrattestis,suggesting
impaired diﬀerentiation of the fetal Leydig cells [35].
4.3. Vinclozolin. Vinclozolin is a dicarboximide fungicide
that has two active metabolites, M1 and M2, which both
have anti-androgenic properties. These metabolites compete
for androgen binding to AR and inhibit DHT-induced tran-
scriptional activation by blocking AR binding to androgen
response elements in DNA [36].
Oral administration of vinclozolin delayed puber-
tal maturation, decreased sex accessory gland growth
and increased serum levels of LH, testosterone and 5α-
androstane, 3α,17β-diol [37]. Studies in vivo have also
revealed that vinclozolin-treated male oﬀspring displayed
female-like anogenital distance (AGD) at birth, retained nip-
ples,undescendedtestes,andsmallsexaccessoryglands[26].
However, experiments in vitro revealed that vinclozolin did4 Journal of Biomedicine and Biotechnology
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Figure 1: Hypothesized eﬀects of environmental antiandrogens
on the hypothalamic-pituitary-testis axis. (A) In normal condition
androgens as testosterone (T) and dihydrotestosterone (DHT)
exert negative inﬂuence on secretion of LHRH and LH by the
hypothalamus and the pituitary, respectively. (B) Antiandrogens
compete with T and DHT for binding to the androgen receptor
(AR). The impaired ability of testosterone (T) to bind AR weakens
the inhibitory feedback of T on LHRH and LH production by
preventing the hypothalamus and anterior pituitary from recog-
nizing the presence of T. This results in hypersecretion of LH
and increased production of T by Leydig cells. Blocking peripheral
AR by antiandrogens inhibits androgen-mediated eﬀects on target
organs potentially resulting in incomplete masculinization and
malformations of the male reproductive tract.
not aﬀect basal and hCG-stimulated testosterone production
by rat Leydig cells in primary culture [38]. Furthermore,
the most sensitive period of rat fetal development to anti-
androgenic eﬀects of vinclozolin was found to be gestational
days 16-17 [39].
4.4. p,p -DDT. p,p -DDE, a metabolite of the environmen-
tally persistent pesticide DDT, acts as an antagonist of AR
b o t hi nv i v oa n di nv i t r o[ 27]. When p,p -DDE (100mg/kg
daily) was administered to rats during fetal development
on days 14–18 of gestation, the AGD was reduced and
hypospadia, retention of nipples, and weight reduction of
androgen-dependent tissues occurred [26]. Moreover, long-
term administration of p,p -DDE to rat pups from the
time of weaning until approximately 50 days of age did
not signiﬁcantly alter the weights of accessory sex organs
or serum hormone levels [27], but resulted in pronounced
reduction of the weights of androgen-dependent tissues in
the Hershberger assay [32]. As with rats, administration of
p,p -DDT or p,p -DDE to rabbits during gestation resulted
in reproductive abnormalities, including cryptorchidism, in
the male oﬀspring [32].
It has also been suggested that p,p -DDE causes abnor-
malities in the reproductive development of wildlife [40].
For instance, high concentrations of p,p -DDE, together
with enhanced susceptibility of the developing reproductive
system to this environmental anti-androgen due to a loss of
geneticdiversity,hasbeensuggestedtocontributetothehigh
incidence of cryptorchidism in the Florida panther [40].
5.PhthalatesandLeydigCellFunction
Phthalates are widely used as plasticizers in the production
of plastics, as well as solvents in inks, and are present, among
other places, in children’s plastics toys, food packaging,
and certain cosmetics [41]. Although diethylhexyl phthalate
(DEHP) and monoethylhexyl phthalate (MEHP) disturb
reproductive development in an anti-androgenic fashion,
neither of these compounds binds to AR [42]. However,
it is now established that these phthalates inhibit Leydig
cell steroidogenesis at diﬀerent ages of fetal development.
For example, prenatal exposure of rats to DEHP attenuates
serum levels of both LH and testosterone in male oﬀspring at
21 and 35 days of postnatal age [43]. In contrast, treatment
with DEHP for two weeks postnatally (beginning at 21 or 35
days of age) results in a signiﬁcant decrease in the activity
of 17βHSD and reduces testosterone production by Leydig
cells by 50%. On the other hand, treatment of adult rats with
DEHP does not inﬂuence their Leydig cell steroidogenesis
[43]. From these ﬁndings it has been concluded that the
eﬀects of DEHP on Leydig cell steroidogenesis are dependent
on the stage of development at the time of exposure and
may involve modulation of the activities of steroidogenic
enzymes and/or serum levels of LH. It has recently been
demonstrated that chronic exposures to low environmen-
tally relevant DEHP levels increased plasma levels of LH,
testosterone, and 17β-estradiol [44]. These metabolic events
coincided with high proliferative activity of Leydig cells,
likely to be induced by the high levels of LH. Moreover,
this study pointed out that DEHP might be indirectly
estrogenic because it increased 17β-estradiol plasma levels,
presumably due to induction of aromatase activity in Leydig
cells by LH [44]. We have recently demonstrated that MEHP
inhibits androgen production activated by human chorionicJournal of Biomedicine and Biotechnology 5
gonadotropin (hCG) in primary cultures of Leydig cells.
This process was associated with decreased expression of
steroidogenic acute regulatory (StAR) protein and reduced
transport of cholesterol into mitochondria but no detectable
adverse eﬀect on steroidogenic enzymes was observed [45].
Moreover, upon exposure to MEHP alone, 5α-reductase
activity was decreased in immature, but not in adult Leydig
cells [45],indicatinghighersusceptibilitytoadverseeﬀectsof
MEHP in young animals.
In line with the above observations and possibly con-
tributing to undermasculinization of male fetuses, prenatal
exposure of rats to di(n-butyl)phthalate (DBP) during days
12–21 of gestation gives rise to Leydig cell hyperplasia and
adenomas, as well as agenesis of the epididymis. Despite
the increased numbers of Leydig cells present after such
exposure, testicular levels of testosterone are reduced at 18
and 21 days of gestation age. It has been suggested that the
proliferation of Leydig cells observed in rat fetuses exposed
to DBP may be a compensatory mechanism designed to
increase testicular steroidogenesis in response to levels of
testosterone that are insuﬃcient to promote normal diﬀer-
entiation of the male reproductive tract [46]. In addition
to reducing testicular levels of testosterone, inhibition of
fetal Leydig cell steroidogenesis by phthalates causes numer-
ous malformations of androgen-dependent tissues in male
rats, including a decrease of AGD, hypospadia, epididymal
agenesis, and testicular atrophy [47]. These abnormalities
indicate a suboptimal masculinization of the Wolﬃan
duct and urogenital sinus. In addition to suppression of
androgen production by fetal Leydig cells, fetal exposure to
phthalates has been shown to reduce Insl3 expression and
to inhibit the transabdominal descent of the testis, most
likely due to an altered maturation of the fetal Leydig cells
[48].
It should be noted that there are very large species
diﬀerences in the response to phthalate exposure. Mice and
marmoset monkeys are almost insensitive to phthalates,
while rats are very sensitive [49]. This is supported by the
observation that administration of high doses of MBP to
pregnant marmosets found no evidence for masculinization
disorders [50], suggesting normal functioning of fetal Leydig
cells. This ﬁnding is consistent with the absence of eﬀect
of MBP on steroidogenesis in vitro by fetal human testis
explants [51]. Similarly, administration of high doses of DBP
or MEHP to pregnant mice did not reduce testicular testos-
terone levels or aﬀect the expression of the steroidogenic
enzyme genes, as seen in the rat [52].
6.EffectsofDioxinonLeydigCellFunction
Polychlorinated dibenzo-p-dioxins such as 2,3,7,8-tetra-
chlorodibenzo-p-dioxin (TCDD) are released into the envi-
ronment as a by-product of the manufacture of chlorinated
hydrocarbons and during other industrial processes, and
are recognized as potent developmental and reproductive
toxins. Upon binding of TCDD to an aryl hydrocarbon
receptor (AhR), the receptor complex translocates into
the nucleus, where AhR heterodimerizes with the aryl
hydrocarbon receptor nuclear translocator (ARNT), binds
to dioxin-responsive enhancer elements and regulates the
transcription of target genes [53]. It has been shown
that the mechanisms of TCDD-induced disorders in the
reproductive system of mammals are multiple and could
involve (i) altered steroidogenesis [54, 55], (ii) reduced
expression of sex steroid and LH receptors [56, 57], and
(iii) induction of cytochrome P450 1 (CYP1) family enzymes
resulting in inactivation of steroid hormones [58]. It is likely
that the adverse eﬀects following a TCDD exposure are
result of a combination of the mechanisms described. The
eﬀects of TCDD on prenatal testis functioning is a dose-
dependent process. It has been recently demonstrated that
prenatal treatment of pregnant rats with low (0.3μg/kg) dose
of TCDD signiﬁcantly reduced intratesticular testosterone
of fetal males, while high (1μg/kg) dose attenuated LH
production by the pituitary of exposed male fetuses [59].
One possible explanation for TCDD-induced decrease in
testicular steroidogenesis could be the reduction in Leydig
cell number. In adult male rats exposed to TCDD, the size
and the number of Leydig cells has been decreased [60].
Interestingly, pharmacological treatment of TCDD-exposed
rats with human chorionic gonadotropin (hCG) preserves
Leydig cell morphology and function [61]. TCDD treatment
is also associated with inhibition of the mobilization of
cholesterol and of the activities of cytochromes P450scc and
P450c17 in Leydig cells [62, 63]. Many if not all of these
alterations in steroidogenesis might be explained by the
recent ﬁnding that TCDD inhibits the formation of cAMP
by cultured Leydig cells [64].
7. Effect of Estrogenic Compounds on
Hormonal Functions of LeydigCells
Estrogen plays an important role in the modulation of
testicular functions [4]. The inhibitory eﬀect of estrogens
on male reproductive function appears, at least in part, to
be mediated by suppression of LH release by the pituitary.
A direct eﬀect of estrogen on Leydig cell steroidogenesis
has also been demonstrated. In vivo experiments have
shown that exogenously administered estradiol can inhibit
steroidogenesis via suppression P450c17 activity in Leydig
cells [65]. These ﬁndings were supported by experiments
in vitro, showing that estradiol may interact directly with
P450c17 as a noncompetitive inhibitor, by binding to the
enzyme and inhibiting its activity [66].
Estrogen receptor α (ERα) is expressed by Leydig cells
[67]a n dE R α null mice were shown to have lower sperm
counts and elevated serum testosterone levels [68]. More-
over, the expression of several steroidogenic enzymes and
factors such as P450c17, 17β-HSD, and StAR was higher in
ERα deleted mice than in wild-type mice [69], suggesting
that ERα-signalling can suppress androgen production in
Leydig cells. Since exogenous compounds of anthropogenic
or natural origin with estrogenic functions are widely
distributed in food, air, and water, it is suggested that such
environmental factors may negatively inﬂuence reproductive
functions in humans.6 Journal of Biomedicine and Biotechnology
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Figure 2: Scheme showing potential sites of action of EDCs on the steroidogenic machinery of Leydig cells. Inhibitory actions of EDCs
on androgen biosynthesis by Leydig cells can be exerted via attenuation cAMP-PKA signaling, inhibition of cholesterol transport by the
StAR/PBR complex, and suppression of expression and/or activity of diﬀerent steroidogenic enzymes (e.g., 3βHSD, P450scc, P450c17,
17βHSD). Attenuation of functioning of one or several such target proteins by EDCs may lead to suppression of androgen production
by Leydig cells and impairment of androgen-dependent physiological processes.
Phytoestrogens are a various group of naturally occur-
ring plant compounds. They are structurally similar to17β-
estradiol and have therefore the ability to cause estrogenic
or/and antiestrogenic eﬀects [70]. Chemically, the phytoe-
strogens can be divided into four main classes: ﬂavonoids
(e.g., genistein, daidzein, naringenin, and kaempferol),
coumestans(coumestrol),lignans (matairesinol andsecoiso-
lariciresinol), and stilbene (resveratrol). The main sources
of phytoestrogens are fruits, vegetables, and legumes [71].
It is important to note that humans can intake of high mg
quantities of ﬂavonoids (e.g., genistein, daidzein) via food
consumption. Low μM levels of genistein are found in serum
of the Japanese population [72] and in infants who consume
large amounts of food products derived from soy beans [73].
Moreover, resveratrol is now popular drug widely used for
prophylactic of cardiovascular diseases and its consumption
may reach several grams per day [74].
The isoﬂavones genistein and daidzein are widely dis-
tributed in human and animal diet and were found to
have a structural similarity to 17β-estradiol (E2) [75]. The
highest amount of ﬂavonoids has been found in soybeans
and soy food (1,2-3,3mg isoﬂavones/g dry weight) as well
as in other types of beans and legumes [71] .T h ep r e s e n c eo f
genistein and daidzein in soy-based infant formula at high-
μM concentrations and the fact that blood concentrations
of the isoﬂavones are 1000 times higher than endogenous
E2 [73] indicate a possibility for interaction with Leydig
cell function and development of the reproductive system in
male infants. Several studies have reported on an inﬂuence
by isoﬂavones on testicular morphology and Leydig cell
development. Treatment of mice with genistein was found to
induce hyperplasia of Leydig cells [76]. Similarly, marmoset
f e dw i t hs o yf o r m u l am i l kd e v e l o p e dl a r g et e s t e sa n d
morphological studies demonstrated an increased number
of Leydig and Sertoli cells when compared with controls
[77]. However, lower concentrations of serum testosterone
associated with an increased number of Leydig cells have
been observed in neonatal marmosets fed with soy milk
formula when compared with animals fed with cow milk
formula [78]. We have demonstrated recently that long-
term dietary administration of genistein to rats suppressed
the steroidogenic response of Leydig cells to hCG and
(Bu)2cAMP by downregulating the expression of P450scc
[30], suggesting that genistein and/or its metabolites have
direct eﬀects on Leydig cell function. The exact cellular
and molecular mechanism behind these eﬀects of genistein
remains to be deﬁned, but may involve activation of the
estrogen receptor by the phytoestrogen. This suggestion
agrees well with the evidence that high estrogen exposure
reduces expression of SF-1, StAR, and CYP17 and attenuates
fetal Leydig cell steroidogenesis in rodents [79, 80].
It has also been reported that long-term dietary adminis-
tration of genistein reduces serum levels of testosterone and
androstenedione without aﬀecting the expression of StAR inJournal of Biomedicine and Biotechnology 7
rats [81]. Furthermore, this compound also suppresses both
basal and LH-stimulated androgen production by rooster
Leydig cells in vitro [82]. However, treatment of MA-10
cells with genistein and resveratrol was shown to suppress
StAR gene expression whereas quercetin enhanced StAR
promoter activity and expression, resulting in increased
progesterone synthesis by the same cells [83]. Moreover,
we have recently demonstrated that resveratrol and certain
analogs structure dependently attenuated steroidogenesis in
Leydig cells through suppression of the expression of StAR
and cytochrome P450c17 [84]. These in vitro eﬀects are
similar to those observed in infant rats after exposure to
potentERsagonistdiethylstilbestrol(DES),wheresigniﬁcant
suppression of testicular StAR expression associated with
decline in plasma testosterone level was demonstrated [85],
suggesting a role for ERs in the regulation of StAR gene
expression and functioning.
Another synthetic compound with estrogenic activity,
which is widely used in industry is bisphenol A (BPA).
It stimulates estrogen dependent cellular proliferation and
induces progesterone receptors [86]. The chemical structure
of BPA is quite similar to that of a very potent estro-
genic compound DES but it is a much weaker estrogen,
approximately 1000- to 2000-fold less potent than estradiol
[86]. It was demonstrated that exposure to environmentally
relevant BPA levels has adverse eﬀects on testicular function
bydecreasingpituitaryLHsecretionandreducingLeydigcell
steroidogenesis [87]. BPA was found to act directly in Leydig
cells because it decreased testosterone production after treat-
ment of Leydig cells in vitro. Inhibition of steroidogenesis
was ER mediated and was associated with inhibition of
enzyme activity [87]. Analysis of steroidogenic enzyme gene
expression by RT-PCR indicated that BPA caused speciﬁc
inhibition of the P450c17 enzyme, which is known to be
inhibited by estradiol [69]. Although BPA suppresses testos-
terone production via decreased LH secretion, there is also
evidencethatBPAinterfereswithLHreceptor-ligandbinding
[88] and uncoupling of LH from the LH receptor potentially
contributestodiminished LHstimulation ofsteroidogenesis.
BPA also suppressed aromatase gene expression and Leydig
cell estradiol biosynthesis in vivo [87]. However, BPA was
recently demonstrated to increase aromatase expression but
reduced testosterone synthesis in rat Leydig R2C cell line in
vitro [89].
Thus, phytoestrogens and BPA may negatively inﬂuence
Leydig cell function resulting in androgen insuﬃciency. This
may contribute to undermasculinization of the male uro-
genital tract resulting in malformations such as hypospadia,
cryptorchidism, and poor development of external genitalia
in the male.
8. Concluding Remarks
EDCs of natural or anthropogenic origin may cause dele-
terious eﬀects on male reproduction and fertility. The
mechanisms of their adverse actions may be diverse but
one important end point is reduced capacity of Leydig
cells to produce androgens. Dysfunction of fetal Leydig cells
induced by EDCs may cause incomplete masculinization
and development of various malformations in the male
reproductive tract of humans and animals. Attenuation of
adult Leydig cell development and function may manifest
by suppressed spermatogenesis and libido. The impaired
Leydig cell function is displayed by a decrease in testosterone
productionasaconsequenceofreducedexpressionofseveral
important steroidogenic factors, including StAR, CYP17A1,
CYP11A1, and 3β-HSD. All these factors being important
components of the steroidogenic machinery may serve as
susceptible targets of EDC actions. However, our knowledge
on the intracellular signalling cascades triggered by EDCs is
still limited. Little is also known about the mechanisms that
determine the selectivity of diﬀerent EDCs for disruption
of particular target molecules involved in steroidogenesis.
Increasing evidence indicate that multiple mechanisms are
causing endocrine disruption including (1) direct eﬀects
on the expression of genes of steroidogenic factors, (2)
suppression of upstream signalling pathways controlling
phosphorylationandactivationoftargetproteinsinvolved in
transport of cholesterol into mitochondria of steroidogenic
cells, and (3) direct interference with AR function blocking
androgen action. A scheme describing potential sites of
action of EDCs attenuating androgen action is presented in
Figure 2.
The action of EDCs on Leydig cell function and the
reproductive potential is a complex process that depends
on the exposure route, dose, the developmental stage of the
exposed target organism, and many other factors. Together,
these factors determine the potential risk for adverse con-
sequences with long-lasting eﬀects on male reproductive
function.
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